Assessments of the Utilities of CSF NPTX2 for Disease Progression in Cognitively Normal Individuals Who Progress to Clinical MCI and AD
Ann Neurol
.
2023 Oct;94(4):618-619.
doi: 10.1002/ana.26768.
Authors
Leslie M Shaw
1
,
Douglas Galasko
2
Affiliations
1
Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
2
Department of Neurosciences, University of California San Diego, La Jolla, CA, USA.
PMID:
37614206
DOI:
10.1002/ana.26768
No abstract available
Publication types
Comment
MeSH terms
Alzheimer Disease* / diagnosis
Amyloid beta-Peptides
Biomarkers
Cognitive Dysfunction*
Disease Progression
Humans
tau Proteins
Substances
Biomarkers
tau Proteins
Amyloid beta-Peptides